New hope for treating neglected flesh-eating disease
Isabella Farrance reports the use of fosravuconazole for treating Mycetoma, and the social factors that may hinder its deployment.
Isabella Farrance reports the use of fosravuconazole for treating Mycetoma, and the social factors that may hinder its deployment.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Ayush Sinha examines metformin’s role in longevity and reports on the highly-anticipated TAME trial set to further investigate its potential.
Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .
Andrew Griffiths reports on results from a small-scale clinical trial showing a potential breakthrough in HIV vaccine development.
Caius Gibeily reports on the promising results from a phase I trial which transfused lab-grown red blood cells into healthy patients.
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
Joshua Mitchell reviews the debate over the role of serotonin in depression, and the evidence on whether antidepressants do actually work.